BACKGROUND: The objective of this study was to examine whether heart rate variability (HRV) measures can be used to detect neurocardiogenic injury (NCI). METHODS: Three hundred and twenty-six consecutive admissions with aneurysmal subarachnoid hemorrhage (SAH) met criteria for the study. Of 326 subjects, 56 (17.2%) developed NCI which we defined by wall motion abnormality with ventricular dysfunction on transthoracic echocardiogram or cardiac troponin-I > 0.3 ng/mL without electrocardiogram evidence of coronary artery insufficiency. HRV measures (in time and frequency domains, as well as nonlinear technique of detrended fluctuation analysis) were calculated over the first 48 h. We applied longitudinal multilevel linear regression to characterize the relationship of HRV measures with NCI and examine between-group differences at baseline and over time. RESULTS: There was decreased vagal activity in NCI subjects with a between-group difference in low/high frequency ratio (β 3.42, SE 0.92, p = 0.0002), with sympathovagal balance in favor of sympathetic nervous activity. All time-domain measures were decreased in SAH subjects with NCI. An ensemble machine learning approach translated these measures into a classification tool that demonstrated good discrimination using the area under the receiver operating characteristic curve (AUROC 0.82), the area under precision recall curve (AUPRC 0.75), and a correct classification rate of 0.81. CONCLUSIONS: HRV measures are significantly associated with our label of NCI and a machine learning approach using features derived from HRV measures can classify SAH patients that develop NCI.
BACKGROUND: The objective of this study was to examine whether heart rate variability (HRV) measures can be used to detect neurocardiogenic injury (NCI). METHODS: Three hundred and twenty-six consecutive admissions with aneurysmal subarachnoid hemorrhage (SAH) met criteria for the study. Of 326 subjects, 56 (17.2%) developed NCI which we defined by wall motion abnormality with ventricular dysfunction on transthoracic echocardiogram or cardiac troponin-I > 0.3 ng/mL without electrocardiogram evidence of coronary artery insufficiency. HRV measures (in time and frequency domains, as well as nonlinear technique of detrended fluctuation analysis) were calculated over the first 48 h. We applied longitudinal multilevel linear regression to characterize the relationship of HRV measures with NCI and examine between-group differences at baseline and over time. RESULTS: There was decreased vagal activity in NCI subjects with a between-group difference in low/high frequency ratio (β 3.42, SE 0.92, p = 0.0002), with sympathovagal balance in favor of sympathetic nervous activity. All time-domain measures were decreased in SAH subjects with NCI. An ensemble machine learning approach translated these measures into a classification tool that demonstrated good discrimination using the area under the receiver operating characteristic curve (AUROC 0.82), the area under precision recall curve (AUPRC 0.75), and a correct classification rate of 0.81. CONCLUSIONS: HRV measures are significantly associated with our label of NCI and a machine learning approach using features derived from HRV measures can classify SAH patients that develop NCI.
Authors: Avinash Kothavale; Nader M Banki; Alexander Kopelnik; Sirisha Yarlagadda; Michael T Lawton; Nerissa Ko; Wade S Smith; Barbara Drew; Elyse Foster; Jonathan G Zaroff Journal: Neurocrit Care Date: 2006 Impact factor: 3.210
Authors: Nader Banki; Alexander Kopelnik; Poyee Tung; Michael T Lawton; Daryl Gress; Barbara Drew; Michael Dae; Elyse Foster; William Parmley; Jonathan Zaroff Journal: J Neurosurg Date: 2006-07 Impact factor: 5.115
Authors: Vivien H Lee; Heidi M Connolly; Jimmy R Fulgham; Edward M Manno; Robert D Brown; Eelco F M Wijdicks Journal: J Neurosurg Date: 2006-08 Impact factor: 5.115
Authors: Andrew M Naidech; Kurt T Kreiter; Nazli Janjua; Noeleen D Ostapkovich; Augusto Parra; Christopher Commichau; Brian-Fred M Fitzsimmons; E Sander Connolly; Stephan A Mayer Journal: Circulation Date: 2005-11-01 Impact factor: 29.690
Authors: Santosh B Murthy; Shreyansh Shah; Chethan P Venkatasubba Rao; Eric M Bershad; Jose I Suarez Journal: J Intensive Care Med Date: 2013-11-07 Impact factor: 3.510
Authors: Poyee Tung; Alexander Kopelnik; Nader Banki; Ken Ong; Nerissa Ko; Michael T Lawton; Daryl Gress; Barbara Drew; Elyse Foster; William Parmley; Jonathan Zaroff Journal: Stroke Date: 2004-01-22 Impact factor: 7.914
Authors: Marta Fedriga; Andras Czigler; Nathalie Nasr; Frederick A Zeiler; Soojin Park; Joseph Donnelly; Vasilios Papaioannou; Shirin K Frisvold; Stephan Wolf; Frank Rasulo; Marek Sykora; Peter Smielewski; Marek Czosnyka Journal: J Neurotrauma Date: 2021-01-12 Impact factor: 4.869
Authors: Benjamin L Ranard; Murad Megjhani; Kalijah Terilli; Hirad Yarmohammadi; John Ausiello; Soojin Park Journal: J Crit Care Date: 2022-07-18 Impact factor: 4.298